Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dicerna Pharmaceutic (NQ: DRNA )

24.64 USD UNCHANGED
Streaming Delayed Price Updated: 5:01 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Dicerna Pharmaceutic

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Dicerna to Participate in the H.C. Wainwright Virtual BioConnect Conference
Dicerna announced that Doug Fambrough will participate in two events at the H.C. Wainwright Virtual BioConnect Conference taking place Jan. 11-14. 
From Business Wire News Releases
Dicerna Announces Novo Nordisk’s Nomination of First Candidate for Development Under RNAi Discovery and Development Agreement and Additional Milestone Achievement
Dicerna announced that Novo Nordisk has nominated its first candidate for development under the existing agreement between the two companies. 
From Business Wire News Releases
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dicerna announced the Company approved the grant of inducement stock options of common stock and restricted stock units among three new employees. 
From Business Wire News Releases
Dicerna Announces Enrollment Completion of PHYOX™2 Pivotal Trial of Nedosiran for Treatment of Primary Hyperoxaluria
Dicerna today announced the enrollment completion of the PHYOX™2 pivotal trial of nedosiran for the treatment of primary hyperoxaluria. 
From Business Wire News Releases
PBE's Holdings Imply 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of DRNA February 2021 Options Trading
Investors in Dicerna Pharmaceuticals Inc (DRNA) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Stocks Generating Improved Relative Strength: Dicerna Pharmaceuticals
Dicerna Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Notable Friday Option Activity: MAXR, DRNA, OPCH
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Maxar Technologies Inc (MAXR), where a total volume of 5,451 contracts has been... 
Tags Stocks
From Market News Video
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dicerna announced that the Company approved the grant of inducement stock options of common stock and restricted stock units among six new employees. 
From Business Wire News Releases
Dicerna Pharmaceuticals Trying To Close In On Key Technical Benchmark
Dicerna Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
Dicerna announced positive updated Phase 1 data on its investigational GalXC™ RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV). 
From Business Wire News Releases
Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for First GalXC™ RNAi Candidate Under Companies’ Global Research Collaboration and Licensing Agreement
Dicerna announced FDA acceptance of the IND Application filed by Lilly for LY3561774, clinical-stage candidate to emerge from their collaboration. 
From Business Wire News Releases
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ... 
Tags ALKS LCTX Small Cap
From Benzinga
Analysts Anticipate ESML Will Reach $33
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Dicerna to Participate in Upcoming Investor Conferences
Dicerna announced that Douglas M. Fambrough, Ph.D., president and CEO, will be participating in fireside chats at two upcoming investor conferences. 
From Business Wire News Releases
Dicerna Presents New Nonclinical Research Highlighting the Application of its RNAi Technology in Extrahepatic Tissues at TIDES Europe 2020
Dicerna will present an update on the Company’s early-stage development of extrahepatic RNAi therapeutics at TIDES Europe 2020. 
From Business Wire News Releases
Dicerna Announces Third Quarter 2020 Financial Results and Provides a Business Update
Dicerna today reported its financial results for the third quarter ended Sep. 30, 2020. 
From Business Wire News Releases
WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NBRV GERN Earnings
From Benzinga
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dicerna announced that the Company approved the grant of inducement stock options of common stock and restricted stock units among nine new employees. 
From Business Wire News Releases
Dicerna Announces Updated Phase 1 Data on RG6346 Investigational Treatment for Chronic Hepatitis B Virus to be Presented in Late-Breaking Session at AASLD’s The Liver Meeting® Digital Experience™ 2020
Dicerna will present updated data related to RG6346, an RNAi investigational therapy, at The Liver Meeting® Digital Experience™ 2020. 
From Business Wire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ICUI BDSI CATB
From Benzinga
Dicerna to Report Third Quarter 2020 Financial Results on November 5, 2020
Dicerna announced that it will release its Q3 2020 financial results and will provide a general business update on Thursday, Nov. 5. 
From Business Wire News Releases
IBD Rating Upgrades: Dicerna Pharmaceuticals Shows Improved Relative Price Strength
A Relative Strength Rating upgrade for Dicerna Pharmaceuticals shows improving technical performance. Will it continue? 
From Investor's Business Daily
Dicerna Presents Positive New Interim Data From PHYOX™3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)
Dicerna announced positive new interim data from its ongoing PHYOX3 open-label trial of nedosiran, an investigational therapy for PH1, PH2 and PH3. 
From Business Wire News Releases
Dicerna Pharmaceuticals (DRNA) Shares Cross Above 200 DMA
In trading on Thursday, shares of Dicerna Pharmaceuticals Inc (DRNA) crossed above their 200 day moving average of $20.51, changing hands as high as $20.74 per share. Dicerna Pharmaceuticals Inc shares... 
Tags Stocks
From Market News Video
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
Shares of Vertex plunged after hours Wednesday after the company announced it planned to stop testing on a drug designed to treat protein deficiencies. VRTX stock fell by double digits. 
From Investor's Business Daily
Noteworthy Thursday Option Activity: X, UNH, DRNA
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in United States Steel Corp. (X), where a total volume of 59,397 contracts has been... 
Tags Stocks
From Market News Video
Dicerna to Participate in the H.C. Wainwright Hepatitis B Virus (HBV) Mini-Conference
Dicerna announced that Doug Fambrough will participate in a virtual fireside chat at the H.C. Wainwright HBV Mini-Conference on Tuesday, Oct. 20. 
From Business Wire News Releases
Implied PBE Analyst Target Price: $75
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.